MultiSearch Tag Explorer MultiSearch Tag Explorer - Explore tags and search results by aéPiot - aéPiot: Independent SEMANTIC Web 4.0 Infrastructure (Est. 2009). High-density Functional Semantic Connectivity with 100/100 Trust...

J A #STARGARDT
aepiot.ro/advanced-sea...
#ADA #EHI
allgraph.ro/advanced-sea...
#LIST OF #IMPROVED #ORDER OF #RED #MEN #MEMBERS
aepiot.ro/advanced-sea...
aepiot.com

Patient Registry | Science Corporation Join the Science Patient Registry to be considered for participation in our vision loss research studies.

Science's PRIMA clinical trials are expanding to Australia, and will include inherited retinal diseases, such as Stargardt disease and retinitis pigmentosa.

Join the patient registry here: patients.science.xyz

#BionicVision #Neurotech #blindness #AMD #stargardt

Oxford team treats first patient in ground-breaking retinal gene therapy trial | NIHR Oxford Biomedical Research Centre

First patient treated @ouhospitals.bsky.social in 2nd phase of clinical trial testing new gene therapy for inherited eye condition #Stargardt disease, which leads to vision loss & blindness in children & adults oxfordbrc.nihr.ac.uk/oxford-team-... @ndcnoxford.bsky.social @nihr.bsky.social

SpliceBio, awarded at the 2025 European LifeStars Awards - Parc Científic de Barcelona The company has been awarded at the 2025 European LifeStars Awards in the “Series B Raise of the Year” category.

#PCBCommunity |🏆 #SpliceBio has won the “Series B Raise of the Year” at the 2025 #EuropeanLifestarsAwards. 🚀 The recognition comes after they recently secured €118 million funding round, that will accelerate SB‑007, the company’s gene therapy for #Stargardt disease, a rare genetic retinal disorder.

AAVantgarde closes $141 million Series B for genetic disease therapies The company plans to use the Series B funding to progress clinical trials for two genetic eye disorders, Stargardt disease and Usher 1B syndrome.

AAVantgarde Bio has raised $141M in Series B funding to advance gene therapies for Stargardt disease and Usher 1B syndrome — two inherited retinal diseases.

#News #Biotech #GeneTherapy #Ophthalmology #RareDiseases #LifeSciences #Stargardt #UsherSyndrome #HealthInnovation

AAVantgarde closes $141 million Series B for genetic disease therapies The company plans to use the Series B funding to progress clinical trials for two genetic eye disorders, Stargardt disease and Usher 1B syndrome.

AAVantgarde Bio has raised $141M in Series B funding to advance gene therapies for Stargardt disease and Usher 1B syndrome — two inherited retinal diseases.

#News #Biotech #GeneTherapy #Ophthalmology #RareDiseases #LifeSciences #Stargardt #UsherSyndrome #HealthInnovation

Washington VisionWalk 2025 {{MetaTags.description}}

I don't post a lot of posts like this online, but my son took over the team fundraising page this year for his #VisionWalk team. If you have a moment to share it, or can contribute, it'd mean the world to him. TYIA 🙏

give.fightingblindness.org/stargardtians

#Stargardt #FFB

Connecting the blind to groundbreaking #BCI vision restoration technology through Science Corporation's patient registry for retinal diseases science.xyz/news/science-patient-reg... via @maxhodak #AMD #RP #Stargardt

Connecting the Blind to Groundbreaking BCI Vision Restoration Technology Through Science Corporation’s Patient Registry for Retinal Diseases | Science Corporation Science Corporation is a clinical-stage medical technology company.

Connecting the blind to groundbreaking #BCI vision restoration technology through Science Corporation's patient registry for retinal diseases science.xyz/news/science... via @maxhodak.bsky.social #AMD #RP #Stargardt

Nanoscope’s Stargardt disease gene therapy improves vision in Phase II Nanoscope will be initiating a Phase III trial of the gene therapy in Stargardt disease by the end of 2025.

Nanoscope’s Stargardt disease gene therapy improves vision in Phase II - buff.ly/A76RdnZ #clinicaltrial #clinicaltrials #stargardt #vision #genetherapy

Safety and efficacy of MCO-010 optogenetic therapy in patients with #Stargardt disease in USA (STARLIGHT): an open-label multicentre phase 2 trial

MCO-010 optogenetic phase 2 results support further investigation for treatment of SD

www.thelancet.com/journals/ecl...
#MedSky #StargardtDisease

#PCBCommunity |📢 #SpliceBio aixeca 118 M€ en la ronda més gran del sector biotecnològic a Espanya, liderada per EQT Life Sciences i Sanofi Ventures. 🔬La #startup destinarà els fons al desenvolupament clínic de la seva teràpia gènica SB-007 per a la malaltia de #Stargardt.

➕ info 👉 tuit.cat/6Ac83

Retinal gene therapy for Stargardt disease with dual AAV intein vectors is both safe and effective in large animal models AAV-intein-based gene therapy for Stargardt disease proves to be safe and efficacious in large animal models.

🔬 AAV-based gene therapy for Stargardt disease is safe and effective in large animal models

A work of #IvanaTrapani and #AAVantgardeBio !!!

📄 #ScienceAdvances | doi.org/10.1126/sciadv.adt9354

#GeneTherapy #Ophthalmology #AAV #Stargardt #VisionResearch

Héctor Orensanz, afectat per una malaltia ocular: "Cal educar sobre com dirigir-se a una persona cega. La inclusió passa per l’educació" - Diari de la Sanitat Fa cinc anys que és cec, però no ha deixat que la malaltia el guanyi. El 2016 li van diagnosticar una malaltia de la vista, Stargardt, que afecta la visió central. Parlem amb ell sobre com li ha canvi...

ENTREVISTA | Héctor Orensanz conviu amb una malaltia ocular, #Stargardt, des del 2016: “No he deixat de fer res, però he canviat la manera de fer les coses”.

✍🏼 Nàstia Mas via @fetasantfeliu.cat

diarisanitat.cat/hector-orens...

Preclinical assessment of splicing modulation therapy for ABCA4 variant c.768G>T in Stargardt disease - Communications Medicine Karjosukarso et al. investigate antisense oligonucleotides targeting aberrant splicing caused by a recurrent ABCA4 variant in Stargardt disease. A candidate therapeutic molecule that shows a favorable...

Check out our latest work! Preclinical in vitro and safety and in vivo biodistribution of #antisense #oligonucleotides targeting a recurrent genetic variant in ABCA4 present in patients with #Stargardt disease. A big first step towards therapeutic intervention.
www.nature.com/articles/s43...

What a duel - the men's 100m T13 (Visual Impairment)

🥇 Skander Djamil ATHMANI 10:42 - Congrats to Athmani for a new record!

🥈 Salum Ageze KASHAFALI 10.47 - Kashafali is visually impaired as a result of #Stargardt Disease

www.rnib.org.uk/your-eyes/ey...

More:

www.paralympic.org/paris-2024/f...

Page not found - Error 404 | UdeMNouvelles

Restoring vision with stem cells www.nouvelles.umontreal.ca/udem-news/news/20151002-... #AMD, #Stargardt

First eye stem cell trial gets go-ahead www.thisislondon.co.uk/standard/article-2399003... #Stargardt, #blind